-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
InnoModels Biotechnology: What are the advantages of genetically engineered homology models?
Author:
InnoModels
Release time:
2024-03-18
In the field of biomedicine, the establishment of disease models is crucial to drug development. In recent years, the Genetic Engineering Homology Model (GEM) of InnoModels Biotechnology has shown great potential in disease simulation and drug discovery by virtue of its unique advantages. In this paper, we will introduce the characteristics of the modeling bioengineered homology model and its application value in drug discovery and development.
Overview of Genetic Engineering Homology Models of InnoModels Biotechnology.
Genetic engineering homology model is to introduce specific genes or gene fragments of target diseases into experimental animals through gene editing technology, so that they express disease phenotypes similar to those of human body. By simulating the gene expression in human disease states, the Genetic Engineering Homology Models of InnoModels Biotechnology provide a more realistic and accurate research environment for drug discovery and development.
Advantages of Genetic Engineering Homology Models from InnoModels Biotechnology
1. Accurate simulation of disease mechanisms: InnoModels' genetic engineering homology model can accurately simulate the pathogenesis of human diseases, including gene mutations and expression abnormalities. This provides researchers with an experimental environment that is closer to the actual disease, which helps to deeply understand the development process of the disease and provides powerful support for drug development.
2. Highly controllable: Through gene editing technology, researchers can precisely manipulate specific genes in experimental animals to realize the controlled occurrence and development of diseases. This facilitates the efficacy assessment and safety evaluation during drug development.
3. Individualized therapeutic strategies: Genetic engineering homology model of InnoModels can simulate the genetic differences between different individuals, providing powerful support for the development of individualized therapeutic strategies. It is expected to improve the therapeutic efficacy and reduce the side effects of drugs by screening and optimizing the drugs according to the genetic characteristics of different individuals.
4. Shorten the R&D cycle: Compared with traditional animal models and clinical trials, InnoModels' genetically engineered homology models are able to simulate the process of disease onset and progression faster, providing earlier efficacy assessment for drug development. This helps to shorten the drug development cycle and accelerate the process of bringing new drugs to market.

Application of Genetic Engineering Homology Model of InnoModels Biotechnology in drug discovery and development
1. Drug target discovery: Genetic engineering homology model of InnoModels Biotechnology can be used to study the key genes and signaling pathways in the process of disease development, which provides powerful support for drug target discovery. By analyzing the gene expression profiles and signaling pathways in the model, researchers can screen out genes and signaling pathways that are closely related to the development of diseases and provide potential targets for new drug development.
2. Drug efficacy evaluation: Genetic engineering homology model of InnoModels can be used to evaluate the efficacy of new drugs in different disease states, providing powerful support for drug development. By applying new drugs to the model, researchers can observe the degree of improvement of the drug on the disease phenotype and evaluate the efficacy and safety of the drug.
3. Individualized therapeutic strategy development: Genetic engineering homology model of InnoModels can simulate the genetic differences between different individuals, which provides strong support for individualized therapeutic strategy development. By screening and optimizing drugs according to the genetic characteristics of different individuals, researchers can develop more accurate and effective individualized treatment plans.
Summary
With the advantages of accurate simulation of disease mechanisms, high controllability, individualized treatment strategies, and shortened R&D cycle, InnoModels Biologics' genetically engineered homology models have demonstrated great potential and application value in the field of new drug discovery and development. With the continuous development of gene editing technology and the biomedical field, GMO homology models will play an even more important role in drug discovery and development in the future, and make a greater contribution to the cause of human health.
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd